Newbridge Financial Services Group’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.7K | Hold |
300
| – | – | 0.01% | 565 |
|
|
2025
Q1 | $41.1K | Hold |
300
| – | – | 0.01% | 407 |
|
|
2024
Q4 | $45.9K | Hold |
300
| – | – | 0.01% | 424 |
|
|
2024
Q3 | $58.2K | Hold |
300
| – | – | 0.02% | 238 |
|
|
2024
Q2 | $69.5K | Sell |
300
-111
| -27% | -$25.7K | 0.03% | 318 |
|
|
2024
Q1 | $88.6K | Buy |
+411
| New | +$88.6K | 0.04% | 307 |
|
|
2023
Q4 | – | Sell |
-500
| Closed | -$129K | – | 1175 |
|
|
2023
Q3 | $129K | Sell |
500
-200
| -29% | -$51.4K | 0.06% | 248 |
|
|
2023
Q2 | $199K | Hold |
700
| – | – | 0.1% | 202 |
|
|
2023
Q1 | $195K | Hold |
700
| – | – | 0.1% | 196 |
|
|
2022
Q4 | $194K | Hold |
700
| – | – | 0.11% | 183 |
|
|
2022
Q3 | $187K | Sell |
700
-26
| -4% | -$6.95K | 0.11% | 197 |
|
|
2022
Q2 | $148K | Sell |
726
-320
| -31% | -$65.2K | 0.09% | 205 |
|
|
2022
Q1 | $220K | Hold |
1,046
| – | – | 0.11% | 181 |
|
|
2021
Q4 | $251K | Buy |
1,046
+250
| +31% | +$60K | 0.12% | 174 |
|
|
2021
Q3 | $225K | Hold |
796
| – | – | 0.14% | 159 |
|
|
2021
Q2 | $276K | Hold |
796
| – | – | 0.17% | 133 |
|
|
2021
Q1 | $223K | Sell |
796
-24
| -3% | -$6.72K | 0.16% | 144 |
|
|
2020
Q4 | $201K | Sell |
820
-78
| -9% | -$19.1K | 0.17% | 136 |
|
|
2020
Q3 | $255K | Buy |
+898
| New | +$255K | 0.25% | 90 |
|